Adiponectin in anorexia nervosa and its modifiers: A meta‐regression study
Authors:
- 11 June 2022
- journal article
- review article
- Published by Wiley in International Journal of Eating Disorders
- Vol. 55 (10) , 1279-1290
Abstract
Objective: Adiponectin, which is secreted from adipose tissue, is a protein hormone. Although a large body of studies have found that circulating adiponectin levels increase in anorexia nervosa (AN) and caloric restriction, the effect of subtypes of AN and modifiers of adiponectin in AN are not yet known.Methods: A systematic search of electronic databases was performed using the search terms “adiponectin,” “anorexia nervosa,” and “eating disorder” up to January 2021. All studies published in peer‐reviewed journals, which included cases and control groups, were selected. The main outcome was the pooled standardized mean difference (SMD) in adiponectin levels between cases and controls, using the random‐effects model. Modifiers of SMD were tested via meta‐regression. Heterogeneity and publication bias were evaluated.Results: Thirty‐four studies met all eligibility criteria. The total sample of AN participants (Hedges' g = .765, p < .0001), and specifically the binge‐eating/purging (Hedges' g = 1.211, p < .00001) and restrictive subtypes (Hedges' g = .913, p < .00001) of AN have increased adiponectin plasma levels compared with healthy controls. Meta‐regression determined that insulin, IGF‐1, BMI, triglyceride, resistin, glucose, IL‐6 levels are significant modifiers of adiponectin levels.Discussion: Compared with controls, adiponectin levels are higher in AN overall, and specifically in the binge‐eating/purging and the restrictive AN subtypes. Many of metabolic parameters of glucose metabolism and pro‐inflammatory molecules modify the relationship between AN and adiponectin levels. Adipose tissue is important to maintain metabolic stability.Public Significance: Anorexia nervosa is a psychiatric disorder associated with a severe decrease in body weight and multiple metabolic abnormalities, including an increase in the hormone adiponectin. In this paper, we used meta‐analysis, a powerful statistical method, to aggregate data from 34 rigorously selected research reports. This enabled us to understand the value of adiponectin to differentiate clinical subtypes of anorexia nervosa and the relations between adiponectin and other important metabolic parameters.Keywords
This publication has 57 references indexed in Scilit:
- Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary SyndromePLOS ONE, 2013
- Adiponectin receptor signalling in the brainBritish Journal of Pharmacology, 2011
- Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine‐1 concentration in anorexia nervosa and obesityClinical Endocrinology, 2011
- Specific adipocytokines profiles in patients with hyperactive and/or binge/purge form of anorexia nervosaEuropean Journal of Clinical Nutrition, 2010
- Leptin concentration indexed to fat mass is increased in untreated anorexia nervosa (AN) patientsClinical Endocrinology, 2009
- Plasma Obestatin Concentrations Are Negatively Correlated with Body Mass Index, Insulin Resistance Index, and Plasma Leptin Concentrations in Obesity and Anorexia NervosaBiological Psychiatry, 2008
- Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expressionClinical Endocrinology, 2007
- Plasma Adiponectin Levels in Women with Anorexia NervosaHormone and Metabolic Research, 2003
- Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—A nationwide register studyInternational Journal of Eating Disorders, 2002
- Central dopaminergic function in Anorexia and Bulimia Nervosa: a psychoneuroendocrine approachPsychoneuroendocrinology, 2001